XML 18 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2013
SEGMENT INFORMATION  
SEGMENT INFORMATION

17. SEGMENT INFORMATION

We have three reportable segments through which we manage our operating activities: (i) chlorovinyls; (ii) building products; and (iii) aromatics. These three segments reflect the organization used by our management for internal reporting purposes. Our chlorovinyls segment produces a highly integrated chain of products, including chlor-alkali and derivative products (chlorine, caustic soda, vinyl chloride monomer ("VCM"), vinyl resins, ethylene dichloride, chlorinated solvents, calcium hypochlorite, muriatic acid and phosgene derivatives) and compound products (vinyl compounds, compound additives and plasticizers). The financial results of the Merged Business are included with the chlorovinyls segment from January 28, 2013, the closing date of the Merger. Our building products segment consists of two primary product groups: (i) window and door profiles and mouldings products, which include extruded vinyl window and door profiles and interior and exterior moulding products; and (ii) vinyl-based home improvement and building products. Our aromatics segment is highly integrated and manufactures cumene products and phenol and acetone products (co-products made from cumene).

Earnings of our segments exclude interest income and expense, unallocated corporate expenses and general plant services and provision for income taxes. Transactions between operating segments are valued at market based prices. The revenues generated by these transfers for the three and nine month periods ended September 30, 2013 and 2012 are provided in the tables below.

(In millions)
  Chlorovinyls   Building
Products
  Aromatics   Eliminations,
Unallocated
and Other
  Total  

Three Months Ended September 30, 2013

                               

Net sales

    $ 750.0     $ 253.4     $ 194.1     $ -     $ 1,197.5  

Intersegment revenues

    $ 61.8     -     -     (61.8 )   $ -  
                       

Total net sales

    $ 811.8     253.4     194.1     (61.8 )   $ 1,197.5  

Long-lived asset impairment charges, net

    $ -     25.8     -     -     $ 25.8  

Transaction related costs and other, net

    $ 1.5     2.9     -     10.4     $ 14.8  

Operating income (loss)

    $ 101.6     (6.7 )   5.2     (22.0 )   $ 78.1  

Depreciation and amortization

    $ 45.7     9.1     0.3     1.7     $ 56.8  

Capital expenditures

    $ 36.0     11.0     2.0     3.9     $ 52.9  

 

                               

Three Months Ended September 30, 2012

                               

Net sales

    $ 329.1     $ 246.2     $ 238.2     $ -     $ 813.5  

Intersegment revenues

    $ 55.7     0.1     -     (55.8 )   $ -  
                       

Total net sales

    $ 384.8     246.3     238.2     (55.8 )   $ 813.5  

Transaction related costs and other, net

    $ 1.3     $ 0.4     -     13.1     $ 14.8  

Gain on sale of assets

    $ (1.9 )   -     -     -     $ (1.9 )

Operating income

    $ 73.8     14.7     11.1     (25.7 )   $ 73.9  

Depreciation and amortization

    $ 11.5     9.9     0.3     1.3     $ 23.0  

Capital expenditures

    $ 7.9     4.7     0.8     1.7     $ 15.1  


 

(In millions)
  Chlorovinyls   Building
Products
  Aromatics   Eliminations,
Unallocated
and Other
  Total  

Nine Months Ended September 30, 2013

                               

Net sales

    $ 2,166.3     $ 660.0     $ 705.2     $ -     $ 3,531.5  

Intersegment revenues

    $ 184.8     -     -     (184.8 )   $ -  
                       

Total net sales

    $ 2,351.1     660.0     705.2     (184.8 )   $ 3,531.5  

Long-lived asset impairment charges, net

    $ -     28.4     -     -     $ 28.4  

Transaction related costs and other, net

    $ 4.7     2.7     -     26.3     $ 33.7  

Operating income (loss)

    $ 311.0     (0.9 )   22.5     (58.7 )   $ 273.9  

Depreciation and amortization

    $ 124.7     26.5     0.9     5.0     $ 157.1  

Capital expenditures

    $ 74.9     24.1     3.0     6.5     $ 108.5  

                               

Nine Months Ended September 30, 2012

                               

Net sales

    $ 998.5     $ 685.8     $ 856.8     $ -     $ 2,541.1  

Intersegment revenues

    $ 194.7     0.4     -     (195.1 )   $ -  
                       

Total net sales

    $ 1,193.2     686.2     856.8     (195.1 )   $ 2,541.1  

Long-lived asset impairment charges (recoveries), net

    $ -     (0.8 )   -     -     $ (0.8 )

Transaction related costs and other, net

    $ 1.3     0.6     -     25.3     $ 27.2  

Gain on sale of assets

    $ (19.3 )   -     -     -     $ (19.3 )

Operating income

    $ 160.2     23.7     46.2     (59.6 )   $ 170.5  

Depreciation and amortization

    $ 34.0     29.4     1.1     3.5     $ 68.0  

Capital expenditures

    $ 32.1     15.1     1.8     6.8     $ 55.8  

Sales by Product Line

The table below summarizes sales by product line:

 
  Three Months Ended September 30,   Nine Months Ended September 30,  
(In millions)
  2013   2012   2013   2012  

Chlorovinyls

                         

Chlor-alkali and derivative products

    $ 634.3     $ 218.2     $ 1,806.0     $ 643.1  

Compound products

    115.7     110.9     360.3     355.4  
                   

Total

    750.0     329.1     2,166.3     998.5  
                   

Building Products

                         

Window and door profiles and moulding products

    88.2     85.9     237.4     243.7  

Outdoor building products

    165.2     160.3     422.6     442.1  
                   

Total

    253.4     246.2     660.0     685.8  
                   

Aromatics

                         

Cumene products

    118.8     171.7     451.1     605.1  

Phenol and acetone products

    75.3     66.5     254.1     251.7  
                   

Total

    194.1     238.2     705.2     856.8  
                   

 

                         

Net Sales

    $ 1,197.5     $ 813.5     $ 3,531.5     $ 2,541.1